Bessette, Louis
Haraoui, Boulos
Rampakakis, Emmanouil
Dembowy, Joanna
Trépanier, Marc-Olivier
Pope, Janet
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 14 April 2023
Accepted: 27 August 2023
First Online: 28 September 2023
Declarations
:
: The ABC study was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice Guidelines. The study protocol and patient enrolment materials were approved by local ethics committees and regulatory agencies prior to initiation of the study. All patients gave written informed consent before any study-related procedures were performed.
: Not applicable.
: L.B. reports speaker’s bureau for AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Fresenius Kabi, Janssen, MSD, Novartis, Organon, Pfizer, Sandoz, Sanofi, Teva, and UCB; consulting for AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Fresenius Kabi, Gilead, Janssen, MSD, Novartis, Organon, Pfizer, Sandoz, Sanofi, Teva, and UCB; grant/research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, MSD, Novartis, Pfizer, Sanofi, and UCB.B.H. reports consulting for and/or grant support from Abbvie, Amgen, Eli Lilly, Pfizer and UCB.E.R. and J.D. are employees of JSS Medical Research.M–O. T. is an employee of Bristol Myers Squibb and may hold stock or stock options.J.P. reports grant/research support from AbbVie, Bristol Myers Squibb, MSD, Pfizer, Roche, Seattle Genetics, UCB; consulting for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Gilead, Janssen, Medexus, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, Teva and UCB.